(Q40053864)

English

Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group.

scientific article published on 6 June 2017

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hiroyuki Fujita

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Shun-Ichi Kimura

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Hideaki Kato

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Nobuhiro Hiramoto

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Naoko Hosono

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Tsutomu Takahashi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Kazuyuki Shigeno

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Naoko Hatsumi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Junichi Miyatake

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Hiroshi Handa

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Nobu Akiyama

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Yoshinobu Kanda

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Minoru Yoshida

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Hitoshi Kiyoi

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Yasushi Miyazaki

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Tomoki Naoe

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Japan Adult Leukemia Study Group (JALSG)

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

publication date

6 June 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

Supportive Care in Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

3515-3521

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28584934%20AND%20SRC:MED&resulttype=core&format=json

22 March 2020

A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

Management of infection in patients with acute leukemia during chemotherapy in Japan: questionnaire analysis by the Japan Adult Leukemia Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

Efficacy and safety of tazobactam/piperacillin as an empirical treatment for the patients of adult and child with febrile neutropenia in Japan

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

Antimicrobial prophylaxis in febrile neutropenia

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey

1 reference

https://api.crossref.org/works/10.1007%2FS00520-017-3775-8

21 January 2018

Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america

1 reference

https://pubmed.ncbi.nlm.nih.gov/28584934

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/28584934

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/28584934

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/28584934

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/28584934

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/28584934

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

1 reference

https://pubmed.ncbi.nlm.nih.gov/28584934

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/28584934

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40053864&oldid=2203347567"